发明名称 |
MEDICAL COMPOSITION FOR PROMOTING FIBRINOLYSIS |
摘要 |
Provided is a novel medical composition capable of promoting fibrinolysis. The medical composition for promoting fibrinolysis contains edoxaban or a pharmaceutically acceptable salt thereof, or a hydrate of those. In addition to edoxaban or a pharmaceutically acceptable salt thereof, or a hydrate of those, the medical composition for promoting fibrinolysis further contains a TAFIa inhibitor. |
申请公布号 |
WO2016104678(A1) |
申请公布日期 |
2016.06.30 |
申请号 |
WO2015JP86178 |
申请日期 |
2015.12.25 |
申请人 |
DAIICHI SANKYO COMPANY,LIMITED |
发明人 |
FURUGORI, TAKETOSHI;MORISHIMA, YOSHIYUKI |
分类号 |
A61K31/444;A61K36/81;A61K45/00;A61P7/02;A61P43/00 |
主分类号 |
A61K31/444 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|